58
Participants
Start Date
April 30, 2013
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2016
Anlotinib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing
Peking Union Medical College Hospital, Beijing
The first hospital affiliated to fujian medical university, Fuzhou
Gansu Province Tumor Hospital, Lanzhou
Sun Yat-Sen University Cancer Center, Guozhou
Harbin medical university affiliated tumor hospital, Harbin
Jiangsu province tumor hospital, Nanjing
Liaoning Province Tumor Hospital, Shenyang
Cancer Hospital of Fudan University, Shanghai
Tianjin Medical University Cancer Hospital, Tianjin
Lead Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
INDUSTRY